1329 related articles for article (PubMed ID: 16161069)
1. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
Bernier J; Cooper JS; Pajak TF; van Glabbeke M; Bourhis J; Forastiere A; Ozsahin EM; Jacobs JR; Jassem J; Ang KK; Lefèbvre JL
Head Neck; 2005 Oct; 27(10):843-50. PubMed ID: 16161069
[TBL] [Abstract][Full Text] [Related]
2. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?
Bernier J; Cooper JS
Oncologist; 2005 Mar; 10(3):215-24. PubMed ID: 15793225
[TBL] [Abstract][Full Text] [Related]
3. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy in patients with resected poor-risk head and neck cancer.
Bernier J; Vermorken JB; Koch WM
J Clin Oncol; 2006 Jun; 24(17):2629-35. PubMed ID: 16763276
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapeutic management of locally advanced head and neck cancer.
Laskar SG; Agarwal JP; Srinivas C; Dinshaw KA
Expert Rev Anticancer Ther; 2006 Mar; 6(3):405-17. PubMed ID: 16503857
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
Budach W; Hehr T; Budach V; Belka C; Dietz K
BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
[TBL] [Abstract][Full Text] [Related]
9. Postoperative reduced dose of cisplatin concomitant with radiation therapy in high- risk head and neck squamous cell carcinoma.
Franchin G; Minatel E; Politi D; Gobitti C; Talamini R; Vaccher E; Savignano MG; Trovo M; Sulfaro S; Barzan L
Cancer; 2009 Jun; 115(11):2464-71. PubMed ID: 19280588
[TBL] [Abstract][Full Text] [Related]
10. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.
Porceddu SV; Campbell B; Rischin D; Corry J; Weih L; Guerrieri M; Grossi M; Peters LJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):365-73. PubMed ID: 15380568
[TBL] [Abstract][Full Text] [Related]
11. Current trials and new aspects in soft tissue sarcoma of adults.
Issels RD; Schlemmer M
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
[TBL] [Abstract][Full Text] [Related]
12. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcome of combined modalities for buccal cancers: unilateral or bilateral neck radiation?
Lin CY; Lee LY; Huang SF; Kang CJ; Fan KH; Wang HM; Chen EY; Chen IH; Liao CT; Cheng AJ; Chang JT
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1373-81. PubMed ID: 18374224
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.
Argiris A; Li Y; Forastiere A
Cancer; 2004 Nov; 101(10):2222-9. PubMed ID: 15452834
[TBL] [Abstract][Full Text] [Related]
15. Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials.
Rewari AN; Haffty BG; Wilson LD; Son YH; Joe JK; Ross DA; Papac RJ; Sasaki CT; Fischer JJ
Cancer J; 2006; 12(2):123-9. PubMed ID: 16630403
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
[TBL] [Abstract][Full Text] [Related]
17. Overview of platinum chemotherapy in head and neck cancer.
Forastiere AA
Semin Oncol; 1994 Oct; 21(5 Suppl 12):20-7. PubMed ID: 7527591
[TBL] [Abstract][Full Text] [Related]
18. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
[TBL] [Abstract][Full Text] [Related]
19. Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer.
Marcial VA; Pajak TF; Kramer S; Davis LW; Stetz J; Laramore GE; Jacobs JR; Al-Sarraf M; Brady LW
Semin Oncol; 1988 Feb; 15(1):39-60. PubMed ID: 3278390
[TBL] [Abstract][Full Text] [Related]
20. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
Fortin A; Caouette R; Wang CS; Vigneault E
Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
